We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

1 hedge funds and large institutions have $17.8M invested in NPS PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 209 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less capital invested

Capital invested by funds: $3.63B → $17.8M (-$3.61B)

100% less funds holding

Funds holding: 213 → 1 (-212)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 209

Holders
1
Holders Change
-212
Holders Change %
-99.53%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
209
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$573M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$313M
3
JHIU
Janus Henderson Investors US
Colorado
-$218M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$213M
5
Wells Fargo
Wells Fargo
California
-$199M
Name Holding Trade Value Shares
Change 		Change in
Stake
NIT
176
NumerixS Investment Technologies
British Columbia, Canada
– -$268K -7,500 Closed
BAAM
177
Baker Avenue Asset Management
California
– -$263K -7,350 Closed
CSS
178
Cubist Systematic Strategies
Connecticut
– -$263K -7,348 Closed
Marshall Wace
179
Marshall Wace
United Kingdom
– -$249K -6,954 Closed
QCMC
180
Quantum Capital Management (California)
California
– -$238K -6,650 Closed
DT
181
Diversified Trust
Tennessee
– -$233K -6,510 Closed
Creative Planning
182
Creative Planning
Kansas
– -$219K -6,130 Closed
PP
183
Peconic Partners
New York
– -$215K -6,000 Closed
HSBC Holdings
184
HSBC Holdings
United Kingdom
– -$208K -5,822 Closed
BNP Paribas Financial Markets
185
BNP Paribas Financial Markets
France
– -$207K -5,800 Closed
LOAMS
186
Lombard Odier Asset Management (Switzerland)
Switzerland
– -$208K -5,780 Closed
GAM
187
Gotham Asset Management
New York
– -$205K -5,743 Closed
DC
188
Deere & Company
Illinois
– -$203K -5,689 Closed
MCM
189
Manchester Capital Management
Vermont
– -$165K -4,621 Closed
FANJ
190
Financial Architects (New Jersey)
New Jersey
– -$143K -4,000 Closed
LTFS
191
Ladenburg Thalmann Financial Services
Florida
– -$142K -3,970 Closed
BJ
192
BlackRock Japan
Japan
– -$129K -3,616 Closed
Teacher Retirement System of Texas
193
Teacher Retirement System of Texas
Texas
– -$109K -3,050 Closed
AIM
194
Advantage Investment Management
Iowa
– -$106K -2,950 Closed
BlackRock
195
BlackRock
New York
– -$101K -2,830 Closed
NFG
196
Next Financial Group
Texas
– -$60K -1,671 Closed
IC
197
Intersect Capital
California
– -$40K -1,122 Closed
SF
198
Synovus Financial
Georgia
– -$36K -1,000 Closed
MWP
199
MYCIO Wealth Partners
Pennsylvania
– -$33K -912 Closed
QT
200
Quantbot Technologies
New York
– -$25K -700 Closed
5 6 7
8
9

NPSP Hedge Fund Activity: Q1 2015 in Review

1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q1 2015, worth a combined $17.8M — down 100% from $3.63B a quarter earlier.

Sellers outnumbered buyers: 209 funds closed out of NPSP and 0 opened new positions — a net loss of 209 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $573M sold.

  • 1 institutional investor held NPS PHARMACEUTICALS INC (NPSP) as of Q1 2015, down from 213 in Q4 2014.
  • Funds reported $17.8M of NPS PHARMACEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new NPS PHARMACEUTICALS INC positions in Q1 2015 and 209 closed out, a net change of -209 holders.
  • The largest NPS PHARMACEUTICALS INC seller in Q1 2015 was Fidelity Investments, an estimated $573M sold.

Based on aggregated 13F filings for Q1 2015.